|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.6 USD | -5.89% |
|
-14.43% | +43.36% |
| 05-31 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
| 05-31 | Equities Mostly Rise as Fed's Preferred Inflation Measure Meets Street Views | MT |
May 17 (Reuters) - Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the Financial Times reported on Friday.
Moderna did not immediately respond to a Reuters request for comment. (Reporting by Sriparna Roy in Bengaluru; Editing by Anil D'Silva)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 142.6 USD | -5.89% | -14.43% | 54.64B | ||
| 100.6 USD | +1.87% | +3.76% | 24.28B | ||
| 28.66 USD | +1.63% | -0.76% | 162B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +43.36% | 54.64B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B | |
| -11.83% | 10.74B |
MODERNA, INC. 
